Order of the General Court (Fourth Chamber) of 7 February 2024.#Neuraxpharm Pharmaceuticals SL v European Commission.#Action for annulment – Medicinal products for human use – Marketing authorisation for the medicinal product Dimethyl fumarate Neuraxpharm – dimethyl fumarate – Letter of the Commission drawing conclusions from a judgment of the Court of Justice – Measure not actionable – Inadmissibility – Hypothetical acts – Manifest inadmissibility.#Case T-226/23.